Net Cash Provided by (Used in) Financing Activities of Bioventus Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Bioventus Inc. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Bioventus Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 29 Mar 2025 was $947,000.
  • Bioventus Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $62,140,000, a 14% decline from 2024.
  • Bioventus Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $54,580,000, a 105% decline from 2023.
  • Bioventus Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $26,653,000, a 143% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

Bioventus Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $62,140,000 -$7,560,000 -14% 01 Jan 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
2024 $54,580,000 -$27,927,000 -105% 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
2023 $26,653,000 -$88,729,000 -143% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2026 2025 FY
2022 $62,076,000 -$211,295,000 -77% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2025 2024 FY
2021 $273,371,000 +$302,940,000 01 Jan 2021 31 Dec 2021 10-K 12 Mar 2024 2023 FY
2020 $29,569,000 -$18,618,000 -170% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2023 2022 FY
2019 $10,951,000 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2022 2021 FY

Bioventus Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $947,000 +$5,189,000 01 Jan 2025 29 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $4,242,000 -$31,622,000 -115% 01 Jan 2024 30 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $27,380,000 +$18,175,000 +197% 01 Jan 2023 01 Apr 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $9,205,000 -$98,321,000 -91% 01 Jan 2022 02 Apr 2022 10-Q 16 May 2023 2023 Q1
Q1 2021 $107,526,000 +$58,744,000 +120% 01 Jan 2021 03 Apr 2021 10-Q 11 May 2022 2022 Q1
Q1 2020 $48,782,000 01 Jan 2020 28 Mar 2020 10-Q 13 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.